Amprius Technologies, Inc. reported its financial results for the third quarter ended September 30, 2026, filing an 8-K on November 10, 2026. The company announced record quarterly revenue of $39.1 million, representing an 83% increase compared to the same period in the prior year.
For the third quarter of 2026, Amprius recorded a net loss attributable to common stockholders of $3.5 million. This figure represents a year-over-year improvement of $0.4 million, as the company reported a net loss of $3.9 million in Q3 2025. The company also noted a GAAP net loss per common share of $0.02 for the quarter, compared to $0.03 in the prior year.
Key financial metrics for the period included a gross profit of $10.5 million, which is an increase of $7.2 million from the previous year. Consequently, the company reported a GAAP gross margin of 27%, up from 15% in Q3 2025. Non-GAAP Adjusted EBITDA for the quarter was a loss of $1.0 million, compared to a gain of $0.2 million in the prior year.
In terms of business developments, Amprius highlighted that U.S. revenues more than doubled quarter-over-quarter to $12.2 million. The company secured a $75 million contract from the U.S. Department of War to produce cells in the U.S., with $22.3 million of that amount currently obligated. This contract aims to support the conversion of an existing battery production line to produce up to 12 million NDAA-compliant cells annually by 2028.
Amprius also introduced a new battery model called SiCore 500, which delivers 500 Wh/kg on conventional lithium-ion manufacturing equipment. The company expanded its relationship with Quantum Systems and began supplying cells to a U.S. aerospace company producing a solar-powered stratospheric platform.
Regarding its 2026 outlook, Amprius raised its revenue expectations to $145 million, up from a previous forecast of at least $140 million. The company expects a gross margin of at least 28% and a net loss of less than $10 million for the full year. Adjusted EBITDA is projected to be at least $2.5 million, and capital expenditures are expected to remain under $10 million.